cultivate(MD) - cultivate(MD)

Capitan Orthopedics a cultivate(MD) portfolio company

Capitan Orthopedics, Inc. Announces Breakthrough Device Designation for its SupraSpacer™ Implant

News / May 5, 2026

cultivate(MD) portfolio company Capitan Orthopedics, Inc. announced that it has been granted Breakthrough Device Designation from the U.S. Food & Drug Administration (FDA) for its SupraSpacer™ implant. “I am excited to announce that Capitan Orthopedics, Inc. has received Breakthrough Device Designation for its SupraSpacer™ implant technology. This is yet another milestone achievement for our team […]

Capitan Orthopedics, Inc. Announces Breakthrough Device Designation for its SupraSpacer™ Implant Read More »

Shoulder Innovations is a cultivate(MD) portfolio company launching I-135RFX humeral stem

Shoulder Innovations Initiates Full Commercial Launch of the InSet® I-135RFX Humeral Stem

News / May 1, 2026

cultivate(MD) portfolio company Shoulder Innovations, Inc., (NYSE: SI) announced full commercial launch of the InSet® I-135RFX Humeral Stem. The commencement of full launch follows a successful limited market release and receipt of additional FDA 510(k) clearance for an expanded set of fracture indications, enabling the InSet™ I-135RFX to now be utilized in all primary, revision,

Shoulder Innovations Initiates Full Commercial Launch of the InSet® I-135RFX Humeral Stem Read More »

Strados Labs Acquires Clinical Trial Business of NuvoAir

News / April 16, 2026

cultivate(MD) portfolio company Strados Labs, the respiratory endpoint intelligence company, announced the acquisition of NuvoAir Clinical Trials from NuvoAir Inc. The transaction, which closed in March 2026, expands Strados’ suite of solutions to include remote and in-clinic spirometry, FeNO measurement, and electronic clinical outcome assessment (eCOA) — complementing its existing technologies for cough monitoring and

Strados Labs Acquires Clinical Trial Business of NuvoAir Read More »

Prana Surgical Announces the Prana System™ Receives FDA Clearance

Press Release / April 2, 2026

Image-guided platform enables minimally invasive, tissue-sparing excision. HOUSTON, April 2, 2026 /PRNewswire-PRWeb/ — Prana Surgical, a Houston-based medical device company, announced today that the U.S. Food and Drug Administration (FDA) has granted clearance for the Prana System™, an electrosurgical device indicated to remove tissue and control bleeding. The Prana System is a sterile, single-use electrosurgical

Prana Surgical Announces the Prana System™ Receives FDA Clearance Read More »

Shoulder Innovations a cultivate(MD) portfolio company

Shoulder Innovations Reports Fourth Quarter and Full Year 2025 Financial Results

Press Release / March 10, 2026

Shoulder Innovations, Inc. (NYSE: SI), a cultivate(MD) portfolio company reported financial results for the fourth quarter and full year ended December 31, 2025. Financial Highlights Full Year and Recent Business Highlights “2025 was a transformational year for Shoulder Innovations. We continued to add new surgeon customers at an accelerated pace, drove rapid commercial adoption of

Shoulder Innovations Reports Fourth Quarter and Full Year 2025 Financial Results Read More »

Nanochon closes $4.1M Seed Prime II Funding Round

News / January 12, 2026

Nanochon, a cultivate(MD) portfolio company developing an implant for treating articular cartilage defects in the knee, has secured commitments to close an oversubscribed funding round, bringing its total capital raised to date to $11.3 million. The round was led by cultivate (MD), with significant contributions from The University of Virginia UVA Seed Fund, WSGR, Wealthing

Nanochon closes $4.1M Seed Prime II Funding Round Read More »

Author name: cultivate(MD)